a strong trendP = 0.06
warfarin in the prevention of stroke/systemic embolism (HR 0.81, 95%CI 0.73–0.91; P < 0.0001), and a strong trend toward fewer major bleedings (HR 0.86, 95% CI 0.73–1.00; P = 0.06).
warfarin in the prevention of stroke/systemic embolism (HR 0.81, 95%CI 0.73–0.91; P < 0.0001), and a strong trend toward fewer major bleedings (HR 0.86, 95% CI 0.73–1.00; P = 0.06).
The reasons for early termination given by the DSMB are an observed trend towards futility for efficacy combined with safety concerns.